Cargando…
Thalidomide for inflammatory bowel disease: Systematic review
BACKGROUND: Thalidomide is an immunomodulatory drug used in the experimental treatment of refractory Crohn disease and ulcerative colitis. We aimed to review the existing evidence on the efficacy and safety of thalidomide in the treatment of inflammatory bowel diseases. METHODS: CENTRAL, MEDLINE, LI...
Autores principales: | Bramuzzo, Matteo, Ventura, Alessandro, Martelossi, Stefano, Lazzerini, Marzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265832/ https://www.ncbi.nlm.nih.gov/pubmed/27472695 http://dx.doi.org/10.1097/MD.0000000000004239 |
Ejemplares similares
-
Inflammatory bowel disease and associated cardiovascular disease outcomes: A systematic review
por: Jaiswal, Vikash, et al.
Publicado: (2023) -
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
por: Nielsen, Ole Haagen, et al.
Publicado: (2015) -
Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review
por: Hu, Huiqin, et al.
Publicado: (2016) -
Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Lin, Lianjie, et al.
Publicado: (2015) -
Heart rate variability and inflammatory bowel disease in humans: A systematic review and meta-analysis
por: Kim, Kyu-Nam, et al.
Publicado: (2020)